Abiopharma

News list

Director Barr Keith 🟢 acquired 78.0K shares (1 derivative) of CARMAX INC (KMX) at $41.71 ($2.3M) Transaction Date: Mar 16, 2026 | Filing ID: 000011

Full text

News bot March 18, 2026, 8:11 p.m.
🔍 Barr Keith (Director)

Company: CARMAX INC (KMX)

Report Date: 2026-03-16
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 78,000
Detailed Transactions and Holdings:
- Acquired 23,975 shares of Common Stock (Direct)
  Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 23,975.00 | transaction_form_type: 4
- Acquired 54,025 shares of Stock Options (Right to Buy) at $41.71 per share (Derivative)
  Date: 2026-03-16 | Code: A | Expires: 2033-03-16 | equity_swap_involved: 0 | shares_owned_after: 54,025.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options.
- F2: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of March 16, 2027, March 16, 2028, March 16, 2029, and March 16, 2030.